首页> 外文期刊>Aesthetic plastic surgery >Randomized Double-Blind Controlled Study on the Safety and Efficacy of a Novel Injectable Cross-linked Hyaluronic Gel for the Correction of Moderate-to-Severe Nasolabial Wrinkles
【24h】

Randomized Double-Blind Controlled Study on the Safety and Efficacy of a Novel Injectable Cross-linked Hyaluronic Gel for the Correction of Moderate-to-Severe Nasolabial Wrinkles

机译:随机的双盲对照研究新型可注射交联透明质凝胶的安全性和功效校正中度至重度鼻皱皱纹的校正

获取原文
获取原文并翻译 | 示例
       

摘要

IntroductionThe current study compares two hyaluronic acid fillers, Ial System Duo and Belotero Basic/Balance, for the treatment of wrinkles. Materials and MethodsThis is a single-center, double-blind randomized controlled study. Inclusion criteria consisted of subjects with bilateral nasolabial wrinkles. Each subject was treated with both products: One was applied on the right side and the other on the left side of the face. The quantity of product injected and any problems or local reactions (erythema, edema, pain or itching) were recorded and reassessed at 3 and 6months and then monthly until complete absorption of the product. The Wrinkle Severity Rating Scale (WSRS) and the Global Aesthetic Improvement Scale (GAIS) were used for the assessment, as well as an ultrasound measurement of the skin thickness.ResultsComplete data were available for 59 subjects. At 3 and 6months, both products showed improvement in the WSRS and GAIS score in the areas treated compared to pre-treatment assessments, although no significant differences were observed between them. No resulting significant differences were observed on skin thickness among the two products, which were completely reabsorbed in 28534days (Ial System Duo) and 27734days (Belotero Basic/Balance; Student's t test: p=0.2181). No significant differences were observed with regard to the subject's satisfaction and adverse events. Conclusions The Ial System Duo achieves long-term permanence (more than 9months confirmed by ultrasound) in correction of moderate and severe wrinkles, similar to Belotero Basic/Balance. Both products showed a high safety profile and a high degree of subject and physician satisfaction.Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
机译:介绍目前的研究比较了两种透明质酸填料,iial系统二重奏和Belotero的基本/平衡,用于治疗皱纹。材料和方法是单中心,双盲随机对照研究。纳入标准由双侧鼻涕皱纹的受试者组成。每个受试者都用两种产品进行处理:一个产品在右侧施加在脸部的左侧。记录并在3至6个月的产品中注射和任何问题或局部反应(红斑,水肿,疼痛或瘙痒),然后每月重新评估产品直至产品的完全吸收。皱纹严重程度评定量表(WSR)和全球审美改善量表(GaIs)用于评估,以及皮肤厚度的超声测量。有59个受试者可获得筛选数据。在3和6个月,两种产品在与预处理评估进行治疗的区域中,在处理的区域中显示出改善,尽管它们之间没有显着差异。没有产生显着差异,在两种产品中观察到皮肤厚度,在28534天(iial System Duo)和27734days(Belotero Basic / Balance;学生的T测试:P = 0.2181)中完全重新吸收。对于受试者的满意和不良事件没有观察到显着差异。结论IAL System Duo在校正中等和严重皱纹的校正中实现了长期持续的长期持久性(超过9个月),类似于Belotero Basic / Baless。两种产品都显示出高安全性和高度的主题和医生满意度。本期刊的证据II velvel要求提交人为每篇文章分配一定程度的证据。有关这些基于证据的药物评级的完整描述,请参阅内容表或在线指示给作者www.springer.com/00266。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号